WhiteLab Gx

Our vision at WhiteLab Genomics is to build a fully integrated solution company that can assist gene therapy companies in their experimental assays. With the development of molecular technologies and artificial intelligence we aim at building a unique platform that will revolutionize the way gene therapies are developed and enable more patients to access gene medicine.

We believe in the gene therapy dream

Our team

Our team is composed of seasoned, passionated and dynamic professionals dedicated to change the way gene therapies are developed today and to give the best experience to our customers. Our expertises are focused on:

  • Cell and gene therapy molecular analyses
  • Deep knowledge of the latest molecular technologies available
  • Scientific understanding of protocols and the capacity to execute them
  • Deep learning and machine learning excellence
David Del Bourgo
CEO

20 years of experience in biotech and healthcare innovations Expertise in strategy, marketing, sales and business development. GE Healthcare background MBA University of Chicago Booth School of Business (USA) MS Université de Technologie de Compiègne (FR)

LinkedIn
Lucia Cinque, PhD
Scientific Advisor

8 years of experience in translating innovative molecular technologies into clinical assays Held roles in R&D operations, IP&L transactions, strategic marketing and partnerships management PhD from Yong Chen Lab @ ENS Paris (FR) MSc Dual Degree from Polimi (IT) & PolyMtl (CA)

LinkedIn
Jean-Philippe Buffet, PhD
Application Scientist

8 years of experience in academic research specialized in molecular biology and genomics. 2 years of experience in original translational research between an academic lab and industrial companies. PhD in microbiology and ecology from Muriel Vayssier-Taussat Lab @ INRA & National Veterinary School of Maisons-Alfort (FR)

LinkedIn